Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
State Street Corp's stake in Arrowhead Pharmaceuticals, Inc. fell to 4.60% (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 11, 2025
State Street Corp's stake in Arrowhead Pharmaceuticals, Inc. fell to 4.60%, 6,371,056 shares, as a passive investor on Jun 30, 2025. Filed Aug 11, 2025 (Schedule 13G).
- Stake
- 4.60%
- Shares
- 6,371,056
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.60% | 6,371,056 |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- State Street Corp
- Arrowhead Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · May 13, 2025
- Schedule 13G · State Street Corp · Feb 5, 2025
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026